Join to View Full Profile
1223 Gateway DrSuite 2GMelbourne, FL 32901
Phone+1 321-473-7177
Fax+1 321-725-7028
Dr. Sunter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Clinical and research neurologist with expertise in neurotoxin therapy for a range of neurological conditions including spasticity, cervical dystonia, blepharospasm, hemifacial spasm, migraine and other pain syndromes.
Education & Training
Baylor College of MedicineResidency, Neurology, 1986 - 1989
Valleywise HealthInternship, Transitional Year, 1985 - 1986
University of Miami Leonard M. Miller School of MedicineClass of 1985
Certifications & Licensure
FL State Medical License 1989 - 2026
TX State Medical License 1988 - 1989
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity EMR, GE Healthcare, 2011, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Centricity EMR, GE Healthcare, 2011, 2013-2014, 2016-2017
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- CD-PROBE: Cervical Dystonia Patient Registry for the Observation of onabotulinumtoxinA Efficacy Start of enrollment: 2009 Jan 01
Publications & Presentations
PubMed
- 56 citationsEffects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM studyDH Miller, RJ Fox, JT Phillips, Michael Hutchinson, Eva Havrdova
Neurology. 2015-03-17 - 1399 citationsTwo Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's DiseaseStephen Salloway, Reisa A. Sperling, Nick C. Fox, Kaj Blennow, William E. Klunk
The New England Journal of Medicine. 2014-01-23 - 1054 citationsPlacebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple SclerosisRobert J. Fox, David Miller, J. Theodore Phillips, Michael Hutchinson, Eva Havrdova
The New England Journal of Medicine. 2012-09-19
Journal Articles
- Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's diseaseHauser, RA et al., Movement Disorders, 3/24/2009
Professional Memberships
- Fellow
- Fellow
- Fellow
External Links
- www.DrSunter.comhttp://www.drsunter.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
